Comparison of surfactant and perfluorochemical liquid enhanced adenovirus-mediated gene transfer in normal rat lung

Molecular Therapy

Volumn 6, Issue 1, 2002, Pages 43-49

  Weiss, Daniel J ^a   Mutlu, Gökhan M ^b,c   Bonneau, Laura ^a   Mendez, Michael ^b   Wang, Ying ^b   Dumasius, Vidas ^b   Factor, Phillip ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adenovirus; FC 75; Gene transfer; Lung; Perfluorochemical liquid; Surfactant; Survanta; galactosidase

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; COMPLEMENTARY DNA; DRUG VEHICLE; GAMMA INTERFERON; INTERLEUKIN 1BETA; LUNG SURFACTANT EXTRACT; PERFLUORO COMPOUND; PROTEIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; ESCHERICHIA COLI; GENE EXPRESSION; GENE TRANSFER; INFLAMMATION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NEUTROPHIL; NONHUMAN; PROTEIN ANALYSIS; RAT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALIA; ESCHERICHIA COLI;

EID: 0036665419     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0632     Document Type: Article

References (42)

1. Johnson, L. G., et al. (1996). In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia. Hum. Gene Ther. 7: 51-59.
2. Pickles, R. J., et al. (1998). Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J. Virol. 72: 6014-6023.
3. Walters, R. W., et al. (1999). Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of of airway epithelia. J. Biol. Chem. 274: 10219-10226.
4. Duan, D., et al. (1998). Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum. Gene Ther. 9: 2761-2776.
5. van Heeckeren, A., Ferkol, T., and Tosi, M. (1998). Effects of bronchopulmonary inflammation induced by pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice. Gene Ther. 5: 345-351.
6. Stern, M., et al. (1998). The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther. 5: 91-98.
7. Virella-Lowell, I., Poirier, A., Chesnut, K. A., Brantly, M., and Flotte, T. R. (2000). Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther. 7: 1783-1789.
8. Crystal, R. G., et al. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8: 42-51.
9. Zuckerman, J. B., et al. (1999). A Phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum. Gene Ther. 10: 2973-2985.
10. Wilson, J. M., Engelhardt, J. F., Grossman, M., Simon, R. H., and Yang, Y. (2000). Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial. Hum. Gene Ther., 5: 501-519.
11. Flotte, T. R., et al. (1998). A fluorescence video-endoscopy technique for detection of gene transfer and expression. Gene Ther. 5: 166-173.
12. - adenovirus vector to airway epithelial cells of normal individuals elicits minimal local host responses. Mol. Ther. 3: 206-215.
13. Katkin, J. P., Gilbert, B. E., Langston, C., French, K., and Beaudet, A. L. (1995). Aerosol delivery of a β-galactosidase adenoviral vector to the lungs of rodents. Hum. Gene Ther. 6: 985-995.
14. McDonald, R. J., et al. (1997). Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primate. Hum. Gene Ther. 8: 411-422.
15. Sene, C., et al. (1995). Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Hum. Gene Ther. 6: 1587-1593.
16. Jobe, A. H., Ueda, T., Whitsett, J. A., Trapnell, B. C., and Ikegami, M. (1996). Surfactant enhances adenovirus-mediated gene expression in rabbit lungs. Gene Ther. 3: 775-779.
17. Katkin, J. P., Husser, R. C., Langston, C., and Welty, S. E. (1997). Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Hum. Gene Ther. 8: 171-176.
18. Factor, P., et al. (1998). Augmentation of lung liquid clearance via adenovirus-mediated transfer of a Na, K-ATPase βl subunit gene. J. Clin. Invest. 102: 1421-1430.
19. Weiss, D. J., Strandjord, T. P., Jackson, J. C., Clark, J. G., and Liggitt, D. (1999). Perfluorochemical liquid-enhanced adenoviral vector distribution and expression in lungs of spontaneously breathing rodents. Exp. Lung Res. 25: 317-333.
20. Weiss, D. J., Bonneau, L., Allen, J. M., Miller, A. D., and Halbert, C. L. (2000). Perfluorochemical liquid enhances adeno-associated virus-mediated transgene expression in lung. Mol. Ther. 2: 624-630.
21. Spragg, R. G. (2001). Surfactant replacement therapy. Clin. Chest Med. 21: 531-541.
22. Leach, C. L., et al. (1996). Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N. Engl. J. Med. 335: 761-767.
23. Otake, K., Ennist, D. L., Harrod, K., and Trapnell, B. C. (1998). Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum. Gene Ther. 9: 2207-2222.
24. Look, D. C., and Brody, S. L. (1999). Engineering viral vectors to subvert the airway defense response. Am. J. Respir. Cell Mol. Biol. 20: 1103-1106.
25. Weiss, D. J., Strandjord, T. P., Liggitt, D., and Clark, J. G. (1999). Perflubron enhances adenoviral-mediated gene expression in lungs of transgenic mice with chronic alveolar filling. Hum. Gene Ther. 10: 2287-2293.
26. Weiss, D. J., Bonneau, L., and Liggitt, D. (2001). Use of perfluorochemical liquid allows earlier detection and use of less adenovirus vector for gene expression in normal lung and enhances gene expression in acutely injured lung. Mol. Ther. 3: 734-745.
27. Raczka, E., Kukowska-Latallo, J. F., Rymaszewski, M., Chen, C., and Baker, J. R. (1998). The effect of synthetic surfactant Exosurf on gene transfer in mouse lung in vivo. Gene Ther. 5: 1333-1339.
28. Duncan, J. D., Whitsett, J. A., and Horowitz, A. D. (1997). Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro. Hum. Gene Ther. 8: 431-438.
29. Clark, L. C., Jr., and Gollan, F. (1966). Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152: 1755-1756.
30. Shaffer, T. H., Wolfson, M. R., and Clark, L. C. (1992). Liquid ventilation. Ped. Pulm. 14: 102-109.
31. Papo, M. C., et al. (1996). Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome. Crit. Care Med. 24: 466-474.
32. Colton, D. M., et al. (1998). Neutrophil accumulation is reduced during partial liquid ventilation. Crit. Care Med. 26: 1716-1724.
33. Rotta, A. T., Gunnarsson, B., Hernan, L. J., Fuhrman, B. P., and Steinhorn, D. M. (1999). Partial liquid ventilation influences pulmonary histopathology in an animal model of acute lung injury. J. Crit. Care 14: 84-92.
34. Croce, M. A., et al. (1998). Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. J. Trauma 45: 273-282.
35. Smith, T. M., Steinhorn, D. M., Thusu, K., Fuhrman, B. P., and Dondona, P. (1995). A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit. Care Med. 23: 1533-1539.
36. Thomassen, M. J., Buhrow, L. T., and Wiedemann, H. P. (1997). Perflubron decreases inflammatory cytokine production by human alveolar macrophages. Crit. Care Med. 25: 2045-2047.
37. 1 subunit increases Na, K-ATPase function in A549 cells. Am. J. Respir. Cell Mol. Biol. 18: 741-749.
38. Weiss, D. J., Liggitt, D., and Clark, J. G. (1997). In situ histochemical detection of β-galactosidase activity in lung: assessment of X-gal reagent in distinguishing Lac-Z gene expression and endogenous β-galactosidase activity. Hum. Gene Ther. 8: 1545-1554.
39. Eustice, D. C., et al. (1991). A sensitive method for the detection of β-galactosidase in transfected mammalian cells. BioTechniques 11: 739-742.
40. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
41. Warner, R. L., et al. (1995). Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am. J. Respir. Cell Mol. Biol. 12: 649-661.
42. Zar, J. H. (1974). Biostatistical Analysis, Prentice-Hall, Inc., Englewood Cliffs, NJ.